Akero Therapeutics Cash from Operations (TTM) Insights

Akero Therapeutics Inc (AKRO)

21.60 -0.19 (-0.87%) USD | NASDAQ | Apr 17, 16:00

21.61 +0.01 (+0.05%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-145.37M
September 30, 2023	-122.25M
June 30, 2023	-97.15M
March 31, 2023	-94.27M
December 31, 2022	-92.52M
September 30, 2022	-93.70M
June 30, 2022	-83.69M
March 31, 2022	-84.21M
December 31, 2021	-79.68M
September 30, 2021	-76.38M
June 30, 2021	-75.28M

Date	Value
March 31, 2021	-77.83M
December 31, 2020	-70.80M
September 30, 2020	-59.06M
June 30, 2020	-58.76M
March 31, 2020	-41.50M
December 31, 2019	-35.63M
September 30, 2019	-26.05M
June 30, 2019	-14.80M
March 31, 2019	-9.731M
December 31, 2018	-4.625M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-145.37M

Minimum

Dec 2023

-14.80M

Maximum

Jun 2019

-75.21M

Average

-77.83M

Median

Mar 2021

Cash from Operations (TTM) Benchmarks